ISOT-Renal Transplant Pathology Old Recorded videos
Sr No
|
Topics
|
Speaker
|
Old Recorded videos
|
---|---|---|---|
1.
|
FROM NEEDLE TO SLIDE:
1. Processing of a renal transplant biopsy 2. Evaluation of the donor kidney 3. Evaluation of the allograft kidney |
Dr. Radhika Krishna Patil
|
|
2.
|
ACUTE T-CELL-MEDIATED REJECTION:
i. Tubulointerstitial (Banff type I and borderline/suspicious) ii. Endarteritis(Banff type II) iii. Arterial transmural inflammation or fibrinoid necrosis (Banff type III). |
Dr. Swarnalata Gowrishankar
|
|
3
|
CHRONICT-CELL-MEDIATED REJECTION:
i. Tubulointerstitial inflammation and fibrosis ii. Transplant arteriopathy *Chronic Active T -cell Mediated Rejection |
Dr. Radhika Krishna Patil
|
|
4.
|
ANTIBODY-MEDIATED REJECTION:
1. Hyperacute 2. Acute i. Acute tubular injury(Banff type I) ii. Capillaritis(Banff type II) iii. Arterial fibrinoid necrosis (Banff type III) |
Dr. Mahesha Vankalakunti
|
|
5.
|
POST RENAL TRANSPLANT DE NOVO GLOMERULAR DISEASES: Focal segmental glomerulo-sclerosis, diabetic nephropathy,Membranous Nephropathy
|
Dr. Shaila Khubchandani
|
|
6.
|
Antibody mediated rejection in renal Transplantation: perspectives
|
Dr. Aruna Vanikar
|
|
7.
|
TMA(Thrombotic Microangiopathy) in Renal Allograft
|
Dr. Pallav Gupta
|
|
8.
|
PROTOCOL BIOPSIES
|
Dr. Kamal Kannodia
|
|
9.
|
POST RENAL TRANSPLANT DRUG TOXICITY:
1. CNI toxicity (cyclosporine, tacrolimus) 2. mTOR inhibitor toxicity (rapamycin, sirolimus) 3. Antiviral drug tubular toxicity (foscarnet, adefovir, tenofovir) 4. Acute allergic tubulointerstitial nephritis |
Dr. Vinita Agarwal
|
|
10.
|
POST RENAL TRANSPLANT VIRAL INFECTIONS:
i. Polyomavirus ii. Adenovirus iii. Cytomegalovirus iv. Herpes simplex |
Dr. Anila Abraham
|
|
11.
|
POST RENAL TRANSPLANT BACTERIAL/FUNGAL INFECTIONS:
i. Acute/chronic pyelonephritis ii. Tuberculosis iii. Malakoplakia |
Dr. Seethalakshmy
|
|
12.
|
Evaluation of Post renal transplant Proteinurea:Pathologist Perspective
|
Dr. Srinivas Bh
|
|
13.
|
CHRONIC ANTIBODY-MEDIATED REJECTION: i. Transplant glomerulopathy ii. Multilamination PTC basement membranes iii. Transplant arteriopathy. *Chronic active ABMR
|
Dr Aravind Sekar
|
|
14.
|
POST RENAL TRANSPLANT LYMPHOPROLIFERATIVE DISEASE : interstitial fibrosis and tubular atrophy, not otherwise classified (IF/TA, NOS)
|
Dr. Manoj Jain
|
|
15.
|
POST RENAL TRANSPLANT RECURRENT PRIMARY DISEASES:
A. Immunologic: IgA nephropathy, Lupus nephritis, anti-GBM disease B. Metabolic: amyloidosis, diabetes, oxalosis C. Other: dense deposit disease, foca lsegmental glomerulosclerosis |
Dr. Lovelesh Kumar Nigam
|
|
16. First Talk
|
Ischemia Reperfusion Injury
|
Dr. Vrushali Deshpande
|
|
16. Second Talk
|
Course Summary In Nutshell
|
Dr. Radhika Krishna Patil
|
|
17.
|
Role of an Electron Microscopy in Renal allograft biopsies
|
Dr. Alok Sharma
|
Sr No
|
Date
|
Time
|
Topics
|
Old Recorded videos
|
---|---|---|---|---|
1.
|
20/12/2023
|
6.30 pm to 7.15 pm
|
FROM NEEDLE TO SLIDE:
1. Processing of a renal transplant biopsy 2. Evaluation of the donor kidney 3. Evaluation of the allograft kidney |
|
2.
|
03/01/2024
|
6.30 pm to 7.15 pm
|
ACUTE T-CELL-MEDIATED REJECTION:
i. Tubulointerstitial (Banff type I and borderline/suspicious) ii. Endarteritis(Banff type II) iii. Arterial transmural inflammation or fibrinoid necrosis (Banff type III). |
|
3
|
17/01/2024
|
6.30 pm to 7.15 pm
|
CHRONICT-CELL-MEDIATED REJECTION:
i. Tubulointerstitial inflammation and fibrosis ii. Transplant arteriopathy *Chronic Active T -cell Mediated Rejection |
|
4.
|
07/02/2024
|
6.30 pm to 7.15 pm
|
ANTIBODY-MEDIATED REJECTION:
1. Hyperacute 2. Acute i. Acute tubular injury(Banff type I) ii. Capillaritis(Banff type II) iii. Arterial fibrinoid necrosis (Banff type III) |
|
5.
|
21/02/2024
|
6.30 pm to 7.15 pm
|
POST RENAL TRANSPLANT DE NOVO GLOMERULAR DISEASES: Focal segmental glomerulo-sclerosis, diabetic nephropathy,Membranous Nephropathy
|
|
6.
|
06/03/2024
|
6.30 pm to 7.15 pm
|
Antibody mediated rejection in renal Transplantation: perspectives
|
|
7.
|
20/03/2024
|
6.30 pm to 7.15 pm
|
TMA(Thrombotic Microangiopathy) in Renal Allograft
|
|
8.
|
03/04/2024
|
6.30 pm to 7.15 pm
|
PROTOCOL BIOPSIES
|
|
9.
|
17/04/2024
|
6.30 pm to 7.15 pm
|
POST RENAL TRANSPLANT DRUG TOXICITY:
1. CNI toxicity (cyclosporine, tacrolimus) 2. mTOR inhibitor toxicity (rapamycin, sirolimus) 3. Antiviral drug tubular toxicity (foscarnet, adefovir, tenofovir) 4. Acute allergic tubulointerstitial nephritis |
|
10.
|
01/05/2024
|
6.30 pm to 7.15 pm
|
POST RENAL TRANSPLANT VIRAL INFECTIONS:
i. Polyomavirus ii. Adenovirus iii. Cytomegalovirus iv. Herpes simplex |
|
11.
|
15/05/2024
|
6.30 pm to 7.15 pm
|
POST RENAL TRANSPLANT BACTERIAL/FUNGAL INFECTIONS:
i. Acute/chronic pyelonephritis ii. Tuberculosis iii. Malakoplakia |
|
12.
|
05/06/2024
|
6.30 pm to 7.15 pm
|
Evaluation of Post renal transplant Proteinurea:Pathologist Perspective
|
|
13.
|
19/06/2024
|
6.30 pm to 7.15 pm
|
CHRONIC ANTIBODY-MEDIATED REJECTION: i. Transplant glomerulopathy ii. Multilamination PTC basement membranes iii. Transplant arteriopathy. *Chronic active ABMR
|
|
14.
|
03/07/2024
|
6.30 pm to 7.15 pm
|
POST RENAL TRANSPLANT LYMPHOPROLIFERATIVE DISEASE IDIOPATHIC: interstitial fibrosis and tubular atrophy, not otherwise classified (IF/TA, NOS)
|
|
15.
|
17/07/2024
|
6.30 pm to 7.15 pm
|
POST RENAL TRANSPLANT RECURRENT PRIMARY DISEASES:
A. Immunologic: IgA nephropathy, Lupus nephritis, anti-GBM disease B. Metabolic: amyloidosis, diabetes, oxalosis C. Other: dense deposit disease, foca lsegmental glomerulosclerosis |
|
16. First Talk
|
07/08/2024
|
6.30 pm to 6.50 pm
|
Hyperperfusion injury: An Interesting case
|
|
16. Second Talk
|
07/08/2024
|
6.50 pm to 7.15 pm
|
Course Summary In Nutshell
|
|
17.
|
21/08/2024
|
6.30 pm to 7.15 pm
|
Role of an Electron Microscopy in Renal allograft biopsies
|
|